![Gonane Norethisterone acetate](https://www.pharmacompass.com/image/flap/gonane-norethisterone-acetate-desktop-headergif-71795.gif)
![Gonane Norethisterone acetate](https://www.pharmacompass.com/image/flap/gonane-norethisterone-acetate-mobile-headergif-11921.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-elagolix-sodium-estradiol-norethindrone-acetate-capsules-71055.pdf
https://www.fiercepharma.com/pharma/myovant-pfizers-myfembree-wins-fda-nod-endometriosis
https://www.expresspharma.in/glenmark-gets-us-fda-nod-for-norethindrone-acetate-and-ethinyl-estradiol-capsules-and-ferrous-fumarate-capsules-1-mg-20-mcg/
https://www.pharmatimes.com/news/nice_draft_final_guidance_for_gedeon_richter_uks_new_uterine_fibroids_treatment_1448342
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-9-2022-1644385243.pdf
https://www.globenewswire.com/news-release/2021/09/09/2294109/0/en/Myovant-Sciences-and-Pfizer-Announce-FDA-Acceptance-of-Supplemental-New-Drug-Application-for-MYFEMBREE-for-the-Management-of-Moderate-to-Severe-Pain-Associated-With-Endometriosis.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf
https://www.ema.europa.eu/en/documents/overview/ryeqo-epar-medicine-overview_en.pdf
https://www.prnewswire.com/news-releases/slayback-pharma-announces-launch-of-merzee-norethindrone-acetate-and-ethinyl-estradiol-capsules-and-ferrous-fumarate-capsules-1-mg20-mcg-generic-equivalent-of-taytulla-301222104.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-19-2020-1597808962.pdf
https://www.fda.gov/news-events/press-announcements/fda-approves-new-option-treat-heavy-menstrual-bleeding-associated-fibroids-women
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202962
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210087
https://health.economictimes.indiatimes.com/news/pharma/glenmark-gets-usfda-nod-for-contraceptive-tablets/70799219
https://health.economictimes.indiatimes.com/news/pharma/glenmark-gets-usfda-nod-for-contraceptive-tablets/70799219
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206490
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209609
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205069
https://www.pharmacompass.com/pdf/news/allergan-issues-nationwide-voluntary-recall-of-taytulla-softgel-capsules-1mg20mcg-1527660267.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210233
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210369
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204847
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206120
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-initiates-recall-of-tablet-mibelas-24-fe-from-us-market/articleshow/60206856.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-23-2017-1503459270.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207580
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209014
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-31-2017-1496224025.pdf
https://www.pharmacompass.com/pdf/news/lupin-pharmaceuticals-inc-announces-a-nationwide-recall-of-mibelas-24-fe-tablets-due-to-out-of-sequence-tablets-and-missing-expirylot-information-1496122678.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2017-1487758756.pdf
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207261
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207260
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207259
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208661
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-amabelz-tablets-in-us-market/articleshow/55439186.cms
http://www.prnewswire.com/news-releases/allergan-announces-launch-of-taytulla-norethindrone-acetate-and-ethinyl-estradiol-capsules-and-ferrous-fumarate-capsules-1-mg20-mcg-the-first-and-only-oral-contraceptive-softgel-capsule-300360428.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205278
http://www.fiercepharma.com/manufacturing/endo-s-par-recalls-half-a-million-birth-control-pills-made-by-patheon
https://www.pharmacompass.com/pdf/news/lupins-generic-ambelz-approved-in-us-for-moderate-to-severe-vasomotor-symptoms-1467005865.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-generic-femhrt-tablets-in-us/articleshow/51877658.cms
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-two-generic-drugs/articleshow/50665913.cms
https://www.pharmacompass.com/pdf/news/aurobindo-pharma-receives-usfda-approval-for-norethindrone-acetate-tablets-1452747746.pdf
https://www.pharmacompass.com/pdf/news/lupins-generic-ethinyl-estradiol-and-norethindrone-acetate-approved-in-us-1448540766.pdf